Boston, MA 06/04/2013 (wallstreetpr) – The share prices of Unilife Corp. (NASDAQ:UNIS) had surged by 15.71 percent to close at $3.83 per share for the end of last trading session on Monday. The shares of injectable drug delivery systems supplier had been trading in the range of $3.33 to $3.92 per share during the day before closing at $0.52 per share higher than the previous close. The shares of Unilife Corp. (NASDAQ:UNIS) had recorded 52 week high price level of $5.17 per share and 52 week low price level of $1.80 per share.
Unilife Corp. (NASDAQ:UNIS) is engaged in the development, commercialization and supply of injectable drug delivery systems. The company enters into collaborations and agreements with hospitals and large pharmaceutical companies thereby seeking to utilize its differentiated drug delivery systems for applications in the clinical development, preliminary testing and lifecycle management of their treatment therapies.
Unilife Corp. (NASDAQ:UNIS) focuses on the development and commercialization of wide range of retractable syringes and its principal product candidate is Unifill ready to fill syringe. The shares of the injectable drug delivery systems manufacturer had been surging to new high levels in the recent days and were also witnessing heavy trading volumes in the market.
Unilife Corp. (NASDAQ:UNIS) witnessed nearly 2.69 million shares being exchanged hands on the trading session on Monday, while the average trading volume of the company is at 1.82 million shares per day. The company presently holds 91.23 million shares outstanding in the market with an institutional ownership of 37 percent of its holdings.
